RxSight (NASDAQ:RXST) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
RxSight beat estimated earnings by 55.81%, reporting an EPS of $-0.19 versus an estimate of $-0.43.
Revenue was up $9.58 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.19 which was followed by a 2.74% increase in the share price the next day.
Here’s a look at RxSight’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.47 | -0.53 | -0.75 | -0.71 |
| EPS Actual | -0.28 | -0.31 | -0.45 | -0.50 |
| Revenue Estimate | 19.21M | 16.28M | 15.05M | 10.98M |
| Revenue Actual | 20.81M | 17.49M | 16.09M | 12.62M |
To track all earnings releases for RxSight visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
